Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
national top stories
sanofi
4
×
amgen
boston top stories
clinical trials
new york
new york blog main
new york top stories
san francisco blog main
biotech
deals
fda
inclisiran
pcsk9
regeneron pharmaceuticals
san francisco top stories
akili interactive labs
alirocumab
alnylam pharmaceuticals
bruce leuchter
cancer
cancer drugs
cholesterol
click therapeutics
clickotine
cobimetinib
data
david benshoof klein
david klein
digital health
digital medicines
digital therapeutics
evolocumab
investing
ipo
joshua steinerman
ldl
What
drug
4
×
medicines
4
×
announced
cholesterol
medco
medicine
aces
acquire
agreed
backs
bets
big
billion
brings
cancer
cash
ceo
click
company
compound
deal
despite
digital
example
family
fda
field
flexible
gain
grabbed
hardest
hit
hottest
hunters
inclisiran
ipo
key
latest
lowering
makers
Language
unset
Current search:
medicines
×
drug
×
sanofi
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
